Nanogen NanoChip 400

$1,999.99 $1,599.99 Buy It Now or Best Offer, $425.00 Shipping, 30-Day Returns, eBay Money Back Guarantee
Seller: vast_trades ✉️ (3,895) 98.6%, Location: Ridgefield, Washington, US, Ships to: WORLDWIDE, Item: 285405839799 Nanogen NanoChip 400. Information taken direct from the manufacturer- "About Nanogen, Inc. Nanogen develops advanced diagnostics to provide physicians and patients worldwide more information to better predict, diagnose and treat disease. The availability of new biomarkers is driving the evolution of medicine, and Nanogen’s vision is to lead the development and growth of advanced diagnostic testing in support of the movement towards individualized healthcare by commercializing a comprehensive portfolio of differentiated products. Diagnostics such as Nanogen’s and those marketed by its subsidiary SYNyX that bring to light information about individuals’ genetic as well as proteomic makeup are facilitating the shift to proactive versus reactive healthcare. Nanogen delivers a variety of products to clinical labs, research institutions and point-of-care testing facilities. These customers are increasing their demand for accurate and reliable diagnostic tools to create a range of tests. These range from single, real-time tests to complex, molecular tests performed on Nanogen’s microarray systems. As a pioneer of nanotechnology and miniaturized biotechnology, Nanogen expects its broad intellectual property portfolio will have diverse applications and licensing opportunities in the future for medical diagnostics as well as other markets. The Opportunity: Molecular Diagnostics Nanogen’s broad suite of diagnostic products makes it possible for the company to take advantage of opportunities in the rapidly growing molecular diagnostics industry. The molecular diagnostics market today is estimated to be approximately $1 billion and is expected to grow at a healthy pace of 30 - 50 percent per year. This growth is fueled by a better understanding of the molecular basis of disease and the need for more genetic tests to improve the prognosis and treatment of patients. Business Strategy Nanogen’s strategy is to identify and commercialize diagnostic tests that meet significant market needs. The company bolstered its capital structure and initiated a business development program to grow its revenue base. The 2004 acquisition of SYNyX provided Nanogen with a variety of point-of-care tests to immediately add to its product portfolio. Later last year, the merger with Epoch Biosciences augmented the product line with 25 complementary analyte specific reagents (ASRs) and other technologies for genetic analysis. These products further leverage Nanogen’s existing sales and marketing infrastructure. Nanogen will continue to identify large volume as well as unique tests with a focus on moving the diagnostic process and information closer to the point of physician and patient interaction. Nanogen will distribute its products around the world through licensing and distribution agreements as well as direct sales efforts to continue to expand its business into new and growing markets in the U.S., Canada and abroad. Products: Addressing Labs’ Needs Molecular Diagnostics & Genetic Testing Available in 2005, the NanoChip® 400 is Nanogen’s second generation advanced molecular diagnostic testing and development platform for clinical research and clinical reference laboratories. The automated multi-purpose system facilitates detection of known genetic sequences using a 400-site NanoChip® Electronic Microarray. The NanoChip® 400 offers increased throughput for running multiplex molecular assays on a smaller sized instrument. Nanogen’s suite of consumable products includes analyte specific reagents (ASRs) for laboratories to develop very simple tests for single mutations or more complex tests for multiple genetic markers. The merger with Epoch Biosciences bolstered Nanogen’s line of ASRs by adding 25 complementary products, allowing Nanogen to offer a broader suite of solutions to its current and targeted customers. These MGB EclipseTM Detection Reagents are compatible with many standard real-time PCR instruments for amplification and quantitation of samples. Nanogen’s internally developed ASRs utilize the NanoChip® microarray for more complex analysis of multiple markers. For example, in 2005 the company will market a panel optimized for use with the NanoChip® 400 that detects the six most common respiratory viruses. The first generation, open platform NanoChip® Molecular Biology Workstation is a resource for researchers identifying the next set of mutations that could be useful as clinical assays. The system’s ability to test a user defined set of mutations, called panels, on one chip makes it easier and more cost-effective to use than research-grade thousand-gene chip arrays. NEXUSdx™ Point-of-Care Diagnostics NEXUSdx™ point-of-care diagnostic tests are marketed to healthcare professionals and research facilities in Europe and Canada by Nanogen’s subsidiary, SYNyX. The highly specialized products diagnose disease at the initial stages to allow for earlier treatment as well as to monitor treatment effectiveness and disease progression. Building expertise in cardiac related health conditions, SYNyX plans to offer an NT-proBNP diagnostic test for congestive heart failure in 2005. Analysts predict the BNP market will have above-average growth and will reach approximately $300 million by 2005 as use increases internationally. Using its Proteomics Discovery Platform™, SYNyX scientists have identified biomarkers in stroke, insulin resistance, type II diabetes, congestive heart failure, Alzheimer's disease and traumatic brain injury. These discovery efforts provide a deep pipeline of potential new and important products for the point-of-care market. Electricity is what makes the NanoChip® different and is a key technological advantage. At the heart of Nanogen's technology is a tiny silicon chip called the NanoChip® Electronic Microarray. The NanoChip® 400 has 400 test sites upon which genetic tests can be conducted. DNA and RNA are moved and concentrated by controlling the current at each test site, improving accuracy, speed and flexibility.  Comes as you see. Condition is used and shows minimal signs of use in a working environment. Removed from service in working condition. Does not come with any cables or software other than power cable.In effort to ship item with minimal chance of damage, we will be shipping via freight. Item will be palletized. When purchasing, please provide business name and shipping address that either has a loading dock or forklift so we can keep shipping costs down for you
  • Condition: Used
  • Condition: Comes as you see. Condition is used and shows minimal signs of use in a working environment. Removed from service in working condition. Does not come with any cables or software other than power cable.
  • Model: Nanogen NanoChip 400
  • Brand: Nanogen

PicClick Insights - Nanogen NanoChip 400 PicClick Exclusive

  •  Popularity - 0 watchers, 0.0 new watchers per day, 244 days for sale on eBay. 0 sold, 1 available.
  •  Best Price -
  •  Seller - 3,895+ items sold. 1.4% negative feedback. Great seller with very good positive feedback and over 50 ratings.

People Also Loved PicClick Exclusive